Recent studies have observed higher fasting blood glucagon concentrations, loss of glucose-stimulated inhibition of glucagon secretion, and disruption of postprandial insulin-glucagon interactions in patients with T2DM compared to patients without DM [4]. This evidence concerns the gene INS and type 2 diabetes mellitus.